DNA and proliferative-cell machinery

DNA and proliferative-cell machinery refers to the integrated system of molecules and enzymes responsible for maintaining genomic integrity and executing cell division (National Cancer Institute). This broad target category includes the DNA double helix itself, which is susceptible to chemical modification by alkylating agents and platinum-based compounds that prevent transcription and replication (PubMed, PMID: 25135323). It also encompasses critical enzymes such as topoisomerases, which manage DNA supercoiling, and antimetabolite targets like dihydrofolate reductase and thymidylate synthase (StatPearls, NBK563158). Furthermore, the machinery includes the microtubule network essential for chromosome segregation during the M phase of the cell cycle. Therapeutic agents targeting these components are central to cancer treatment, aiming to induce cell cycle arrest and apoptosis in rapidly proliferating tumor cells. Despite their efficacy, these drugs often lack high specificity for malignant tissue, resulting in damage to healthy, rapidly dividing cells in the bone marrow and gastrointestinal tract (NIH, National Institute of General Medical Sciences).

Other names

DNA replication machineryCell cycle machineryCytotoxic targetsDNA synthesis apparatusProliferative machinery

Inhibition of DNA synthesis and replication through DNA alkylation, intercalation, antimetabolite-mediated enzyme inhibition, and disruption of microtubule dynamics during mitosis.